Cumberland Infirmary is a hospital in Carlisle, Cumbria, England. It is managed by the North Cumbria Integrated Care NHS Foundation Trust.

During the past decade, North Cumbria University Hospitals conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Cumbria University Hospitals" #1 sponsor was "Ellipse Technologies, Inc." with 1 trials, followed by "Royal Marsden NHS Foundation Trust" with 1 trials sponsored, "Smith & Nephew, Inc." with 1 trials sponsored, "The Christie NHS Foundation Trust" with 1 trials sponsored and "University Hospital Southampton NHS Foundation Trust" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Cumbria University Hospitals" #1 collaborator was "Cancer Research UK" with 1 trials as a collaborator, "Smith & Nephew Orthopaedics AG" with 1 trials as a collaborator and "University of Southampton" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "North Cumbria University Hospitals" are "Ampullary Cancer" (1 trials), "Biliary Tract Cancer" (1 trials), "Breast Cancer Female" (1 trials), "Breast Neoplasm" (1 trials) and "Cervical Cancer" (1 trials). Many other conditions were trialed in "North Cumbria University Hospitals" in a lesser frequency.

Most popular intervention types in "North Cumbria University Hospitals" are "Device" (2 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "5 FU" (1 trials), "Active Symptom Control" (1 trials), "Ellipse IM HTO Nail" (1 trials), "Implantation of Integra Cadence Total Ankle Sysyem" (1 trials) and "L-folinic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "North Cumbria University Hospitals" are 5 trials for "All" genders.

Currently, there are NaN active trials in "North Cumbria University Hospitals". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in North Cumbria University Hospitals, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in North Cumbria University Hospitals, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

North Cumbria University Hospitals has several departments that took part in Clinical trials: "Neurosciences department, Penrith Hospital, Cumbria Partnership NHS Foundation Trust" - 3 trials